Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.610
-0.020 (-1.23%)
Feb 11, 2026, 4:00 PM EST - Market closed
Invivyd Market Cap
Invivyd has a market cap or net worth of $454 million as of February 12, 2026. Its market cap has increased by 820.78% in one year.
Market Cap
454.00M
Enterprise Value
371.71M
1-Year Change
820.78%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $454.00M, a decrease of -79.96%. That is a compound annual growth rate of -29.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 459.64M | -32.85% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 472.83M |
| 4D Molecular Therapeutics | 458.56M |
| Tectonic Therapeutic | 456.12M |
| Kyverna Therapeutics | 453.04M |
| Vanda Pharmaceuticals | 447.36M |
| LENZ Therapeutics | 444.94M |
| Zura Bio | 442.82M |
| DiaMedica Therapeutics | 439.34M |